-

ACADIA HEALTHCARE INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Acadia Healthcare Company, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ACHC

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ: ACHC) breached their fiduciary duties to Acadia Healthcare and its shareholders.

CLICK HERE TO LEARN MORE

Scott+Scott is investigating whether members of the Acadia Healthcare board of directors or senior management failed to manage Acadia Healthcare in an acceptable manner, in breach of their fiduciary duties to Acadia Healthcare, and whether Acadia Healthcare and its shareholders have suffered damages as a result.

On September 1, 2024, the New York Times published an investigative article detailing unlawful and unethical practices at Acadia Healthcare, including improperly detaining psychiatric patients in Acadia Healthcare facilities against their will. A second article was published on December 7, 2024, detailing fraud and falsification of records at Acadia Healthcare methadone clinics. On April 22, 2025, the New York Times published a third article regarding Acadia Healthcare, alleging suicides and rapes at one of Acadia Healthcare’s facilities outside Chicago due in part to insufficient staffing.

Acadia Healthcare has acknowledged several governmental investigations on the above, including by the Criminal Division of the U.S. Department of Justice and the Securities and Exchange Commission, as well as Congressional inquiries. In addition, a securities class action lawsuit has been filed against Acadia Healthcare and its top management.

What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER

If you own shares of Acadia Healthcare, you may have legal claims against Acadia Healthcare’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Us

Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations.

With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief.

Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:ACHC

Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
600 W. Broadway, Suite 3300, San Diego, CA 92101
(844) 818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation’s Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 4, 2026, B...

SIX FLAGS ENTERTAINMENT CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Six Flags Entertainment Corporation’s Directors and Officers for Breach of Fiduciary Duties – FUN

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Six Flags Entertainment Corporation (NYSE: FUN) failed to manage Six Flags in an acceptable manner, breaching their fiduciary duties to Six Flags, and whether Six Flags and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On October 12, 2026, a man died after be...

DISTRIBUTION SOLUTIONS GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Distribution Solutions Group, Inc.’s Directors for Breach of Fiduciary Duties – DSGR

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether the directors of Distribution Solutions Group, Inc. (NASDAQ: DSGR) approved a buyout of Distribution Solutions Group for inadequate consideration, breaching their fiduciary duties to Distribution Solutions Group’s shareholders, and whether Distribution Solutions Group’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what sharehol...
Back to Newsroom